Moreover, SIRT3 activation promotes stemness, metastasis, and EMT in NSCLC by activating the Wnt/β-catenin pathway through modulating the deacetylation of replication timing regulatory factor 1 (RIF1) 77. Here, SIRT3 is linked to non-small cell lung carcinoma.